For the quarter ending 2026-03-31, RLYB has $54,472K in assets. $4,195K in debts. $41,299K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 41,299 | 31,374 | 32,122 | 9,445 |
| Marketable securities | 5,496 | 23,362 | 27,197 | 36,304 |
| Prepaid expenses and other current assets | 6,695 | 6,517 | 7,308 | 4,516 |
| Total current assets | 53,490 | 61,253 | 66,627 | 50,265 |
| Property and equipment, net | 20 | 23 | 26 | 61 |
| Operating lease right-of-use assets | 152 | 175 | 198 | 51 |
| Investment in joint venture | - | - | - | 626 |
| Other assets, noncurrent | 810 | 810 | 810 | - |
| Total assets | 54,472 | 62,261 | 67,661 | 51,003 |
| Accounts payable | 940 | 126 | 269 | 119 |
| Accrued expenses | 3,101 | 3,791 | 3,736 | 4,226 |
| Operating lease liabilities | 99 | 94 | 90 | 58 |
| Deferred revenue | 0 | 212 | 424 | 636 |
| Total current liabilities | 4,140 | 4,223 | 4,519 | 5,039 |
| Operating lease liabilities, noncurrent | 55 | 82 | 108 | - |
| Deferred revenue, noncurrent | - | 0 | 0 | 0 |
| Total liabilities | 4,195 | 4,305 | 4,627 | 5,039 |
| Common stock, 0.0001 par value per share 200,000,000 shares authorized as of march 31, 2026 and december31, 2025 and 5,290,236 and 5,283,321 shares issued and outstanding as of march 31, 2026 and december31, 2025, respectively | 4 | 4 | 4 | 4 |
| Additional paid-in capital | 360,548 | 359,932 | 359,152 | 358,105 |
| Accumulated other comprehensive gain | 1 | 18 | 24 | 17 |
| Accumulated deficit | -310,276 | -301,998 | -296,146 | -312,162 |
| Total stockholders' equity | 50,277 | 57,956 | 63,034 | 45,964 |
| Total liabilities and stockholders' equity | 54,472 | 62,261 | 67,661 | 51,003 |
Rallybio Corp (RLYB)
Rallybio Corp (RLYB)